Instructions Bobotik oral drops emulsion 66.66 mg/ml bottle with dropper cap 30 ml
Composition
active ingredient: simethicone (dimethicone activated with silicon dioxide in the form of a 30% emulsion);
1 ml of emulsion contains simethicone (dimethicone activated with silicon dioxide in the form of a 30% emulsion) 66.66 mg; 1 ml contains approximately 27 drops;
excipients: sodium saccharin, sodium carmellose, methyl parahydroxybenzoate (E 218), propyl parahydroxybenzoate (E 216), citric acid monohydrate, raspberry flavoring (ethanol 96%, isopropyl alcohol, flavorings), purified water.
Dosage form
Oral drops, emulsion.
Main physicochemical properties: thick opaque emulsion of whitish or light cream color with a sweet-sour taste and raspberry odor.
Pharmacotherapeutic group
Drugs used for functional gastrointestinal disorders.
ATX code A03A X13.
Pharmacological properties
Pharmacodynamics
Simethicone (activated dimethicone) is a combination of methylated linear siloxane polymers stabilized by trimethylsiloxyl groups with silicon dioxide. By reducing the surface tension at the interface, it hinders the formation and promotes the destruction of gas bubbles in the nutrient suspension and mucus of the gastrointestinal tract (GI). The gases released in this case can be absorbed by the intestinal walls or excreted due to peristalsis. This prevents the formation of large gas-mucus conglomerates that cause painful bloating. During ultrasound and radiography, it prevents the appearance of image defects; promotes better irrigation of the colon mucosa with contrast agents, preventing the rupture of the contrast film.
Pharmacokinetics
After oral administration, simethicone is not absorbed from the gastrointestinal tract and is excreted unchanged in the feces. Due to its chemical inertness, it does not affect microorganisms and enzymes present in the gastrointestinal tract. It does not reduce the absorption of food, does not change the reaction and volume of gastric juice.
Indication
Symptomatic treatment of digestive tract disorders associated with gas accumulation, for example, with flatulence, with colic in infants. Preparation for diagnostic examinations of the abdominal cavity and small pelvis (X-ray examinations, ultrasound diagnostics and gastrofibroscopy). As an antifoam in acute poisoning with surfactants (washing powders or other detergents).
Contraindication
Hypersensitivity to simethicone and/or other components of the drug; complete intestinal obstruction
Interaction with other medicinal products and other types of interactions
Possible impaired absorption of oral anticoagulants.
Levothyroxine can bind to simethicone. Therefore, the absorption of levothyroxine may be impaired when simethicone is used simultaneously in infants with thyroid diseases.
Application features
The drug should be used with caution in patients with obstructive diseases of the gastrointestinal tract.
Bobotik does not contain sugar, so it can be used by people with diabetes.
It is not recommended to drink carbonated drinks while using Bobotik.
Taking the drug may distort the results of some diagnostic tests, such as a test using guaiac resin.
If complaints recur or if gastrointestinal complaints persist, you should consult a doctor.
The medicine contains parahydroxybenzoate and propylhydroxybenzoate, which may cause allergic reactions, including delayed-type reactions.
Ability to influence reaction speed when driving vehicles or other mechanisms
Does not affect.
Use during pregnancy or breastfeeding
To date, there is no evidence that simethicone has a teratogenic or embryotoxic effect. The drug can be used during pregnancy or breastfeeding as prescribed by a doctor.
Method of administration and doses
The drug should be used internally after consulting a doctor.
Shake before use until a homogeneous emulsion is obtained.
To accurately measure the dose of the drug, the bottle should be held vertically during instillation.
Take the drug during or after meals, and if necessary, before bedtime.
For digestive tract disorders caused by increased gas accumulation, for example, flatulence, colic in infants:
The drug is usually used after meals 3-5 times a day (including before bedtime):
For children under 1 year of age, add 16 drops to a bottle of baby food at each feeding or with a small spoon, give before or after breastfeeding; For children 1 to 6 years of age, 16 drops 3-5 times a day; For children 6 to 14 years of age, 16-32 drops 3-5 times a day; For children 14 years of age and older and adults, 32 drops 3-5 times a day.
The duration of treatment depends on the presence of complaints and is decided by the doctor individually.
Preparation for diagnostic procedures:
X-ray examinations, ultrasound diagnostics.
One day before the examination, adults should be given 32 drops 3 times a day and 32 drops once in the morning before the examination. As an addition to the contrast agent suspension, adults should add 64-128 drops of Bobotik (2.4-4.8 ml) per 1 liter of contrast mixture to obtain a double-contrast image.
gastroduodenoscopy
Before performing endoscopy, use 64-128 drops (2.4-4.8 ml) of Bobotik.
During endoscopy, if necessary, a few milliliters of emulsion can be injected through the endoscope channel to eliminate gas bubbles that interfere with the examination.
As an antidote for surfactant poisoning.
In case of poisoning with detergents, children should use from 1.5 to 6 ml (40-160 drops or up to the contents of the bottle) of the drug, and adults should use from 6 to 12 ml of the drug (up to the contents of the bottle).
Bobotik can also be used in the postoperative period.
If gastrointestinal disturbances recur and/or persist, a clinical examination should be performed.
Children
The drug can be used in pediatric practice.
Overdose
The drug is chemically inert and is not absorbed from the gastrointestinal tract.
To date, there is no information about an overdose of Bobotic.
In case of unusual reactions, you should consult a doctor regarding further use of the drug.
Adverse reactions
No side effects were observed when taking the drug in recommended doses.
Allergic reactions are possible (skin rash, itching, hives).
Expiration date
3 years.
The shelf life after opening the bottle is 2 months.
Do not use after the expiry date stated on the packaging.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 ° C. Keep out of the reach of children.
Packaging
30 ml in dark glass bottles with a polyethylene dropper stopper and a polyethylene screw cap. One bottle in a cardboard box.
Vacation category
Without a prescription.
Producer
MEDANA PHARMA Joint Stock Company/MEDANA PHARMA Spolka Akcyjna.
Location of the manufacturer and its business address
57, Polskiej Organizacji Wojskowej Str., 98-200 Sieradz, Poland.
